Indoco Remedies Ltd.
Snapshot View

345.45 -7.60 ▼-2.2%

18 August 2022, 04:01:00 PM
Volume: 13,622

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indoco.com
Market Cap 3,177.34 Cr.
Enterprise Value(EV) 3,407.75 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 16.68 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 20.71 Trailing Twelve Months Ending 2022-06
Industry PE 32.29 Trailing Twelve Months Ending 2022-06
Book Value / Share 102.36 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.37 Calculated using Price: 345.45
Dividend Yield 0.44 Period Ending 2021-03
No. of Shares Subscribed 9.22 Cr. 92,150,355 Shares
FaceValue 2
Company Profile
Indoco Remedies is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company caters to both domestic and International markets. Indoco has strengthened its wings in the international markets and offers complete solutions, including product development, manufacture and supply of Finished Dosages, APIs and Intermediates to generic companies worldwide. The company has a large basket of products backed by ANDAs / eCTD Dossiers and Drug Master Files (DMFs). Expertise in Research & Development, backward integration in API in select products, own CRO set-up, excellence in Finished Dosages manufacturing and a strong customer base will ensure consistent growth in the Company’s Domestic, as well as International business.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.15%
1 Week
-8.66%
1 Month
-9.95%
3 Month
-7.00%
6 Month
-9.22%
1 Year
-25.26%
2 Year
+35.68%
5 Year
+78.34%
10 Year
+485.51%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 13.98 13.32 16.97 14.96 12.55 6.21 -0.43 3.60 12.85
Return on Capital Employed (%) 18.33 16.84 20.63 16.72 11.80 7.62 1.23 5.78 15.67
Return on Assets (%) 8.53 8.17 10.52 9.15 7.22 3.42 -0.24 1.96 7.23

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 414 457 519 577 651 675 661 680 769 905
Non Curr. Liab. 78 70 65 66 147 125 116 101 158 157
Curr. Liab. 199 202 262 303 390 417 446 459 407 425
Minority Int. 0 0
Equity & Liab. 692 729 846 946 1,189 1,218 1,223 1,240 1,334 1,486
Non Curr. Assets 416 425 460 481 617 679 684 676 712 712
Curr. Assets 276 305 385 465 572 539 538 563 623 774
Misc. Exp. not W/O
Total Assets 692 729 846 946 1,189 1,218 1,223 1,240 1,334 1,486

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 631 733 857 1,008 1,075 1,042 968 1,107 1,242 1,562
Other Income 2 4 2 4 6 8 7 5 9 3
Total Income 632 737 859 1,012 1,081 1,050 975 1,111 1,251 1,565
Total Expenditure -538 -614 -692 -840 -920 -910 -892 -986 -1,023 -1,250
PBIDT 94 122 167 172 160 140 83 126 227 314
Interest -22 -19 -11 -12 -6 -24 -21 -26 -22 -14
Depreciation -24 -31 -47 -61 -63 -68 -72 -71 -73 -77
Taxation -6 -14 -27 -17 -14 -7 6 -4 -39 -70
Exceptional Items
PAT 43 58 83 82 77 41 -3 24 93 154
Minority Interest 0 0
Share Associate
Other Related Items 0
Consolidated Net Profit 43 58 83 82 77 41 -3 24 93 154
Adjusted EPS 5 6 9 9 8 4 0 3 10 17

Cash Flow View Details >>

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 69 99 109 112 89 123 132 123 82
Cash Fr. Inv. -43 -41 -88 -111 -171 -135 -104 -56 -67
Cash Fr. Finan. -24 -59 -20 -2 132 -39 -16 -64 -30
Net Change 2 -1 1 0 50 -51 12 3 -14
Cash & Cash Eqvt 11 10 10 10 60 9 21 24 9

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 58.69 58.69 58.69 58.69 58.54 58.69 58.69 58.69 58.69
Public 41.31 41.31 41.31 41.31 41.46 41.31 41.31 41.31 41.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 16 Aug 2022
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015Execution of Share Purchase and Shareholders Agreement and Power Purchase Agreement for acquisition of 26% stake in Kanakal Wind Energy Private Limited -
Tue, 16 Aug 2022
Announcement under Regulation 30 (LODR)-Acquisition
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015Execution of Share Purchase and Shareholders Agreement and Power Purchase Agreement for acquisition of 26% stake in Jalansar Wind Energy Private Limited
Tue, 16 Aug 2022
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015Execution of Share Purchase and Shareholders Agreement and Power Purchase Agreement for acquisition of 26% stake in Jalansar Wind Energy Private Limited

Technical Scans View Details >>

Thu, 18 Aug 2022
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,779.08 916.00 -0.5%
Divi's Laboratories Ltd. 99,402.06 3,744.40 -0.1%
Cipla Ltd. 83,298.12 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. 70,326.13 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. 61,347.88 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. 52,831.33 1,564.95 +0.5%
Piramal Enterprises Ltd. 46,812.69 1,961.10 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.51 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 32.01 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 33.50 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.51 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.51 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.12 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 24.90 1,961.10 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 8.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-06 3.88 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.47 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.33 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-06 1.31 1,961.10 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,961.10 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,961.10 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 916.00 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,744.40 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,033.00 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,225.55 -2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,270.55 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,564.95 +0.5%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,961.10 -0.7%

FAQ's On Indoco Remedies Ltd.

Can I Buy Indoco Remedies Shares now?

What is the Share Price of Indoco Remedies?

What is the Relative Strength Index (RSI) Value of Indoco Remedies?

What is the Market Capital (MCAP) of Indoco Remedies?

What are the key metrics to analyse Indoco Remedies?

What is the Price Performance of Indoco Remedies?